Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Double-Blind Randomized Placebo-Controlled Trial of Combination Therapy to Treat COVID-19 Infection

NCT04482686 is registered in ClinicalTrials.gov with ProgenaBiome as lead sponsor.

NCT NCT04482686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04482686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Double-Blind Randomized Placebo-Controlled Trial of Combination Therapy to Treat COVID-19 Infection
Lead sponsor
ProgenaBiome
Phase
Phase 1
Overall status
Completed
Start date
December 9, 2020
Completion date
July 15, 2022
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, coronavirus infection, coronavirus-19, covid, covid-19, sars-cov infection, sars-cov2